Boehringer Ingelheim Pharma GmbH & Co KG in Consumer Health (Germany)

September 2016 | 2 pages | ID: BF5E41CFF62EN
Euromonitor International Ltd

Abstracts

Boehringer Ingelheim focuses most of its efforts on the development of innovative products and solutions. Part of its value through innovation and a lead and learn strategy is a strong concentration on individuals and teams alike. Investment to ensure the highest standards of research, product development and manufacturing, marketing and distribution is planned to support future success.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
  Summary 2 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
Competitive Positioning
  Summary 3 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2016